Literature DB >> 16965214

Reversal of antipsychotic-induced hyperprolactinemia, weight gain, and dyslipidemia by aripiprazole: A case report.

Shih-Ku Lin, Chih-Ken Chen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16965214     DOI: 10.4088/jcp.v67n0821a

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  3 in total

1.  Switching to aripiprazole as a strategy for weight reduction: a meta-analysis in patients suffering from schizophrenia.

Authors:  Yoram Barak; Dov Aizenberg
Journal:  J Obes       Date:  2010-08-25

2.  The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study.

Authors:  Kojiro Hashimoto; Norio Sugawara; Masamichi Ishioka; Kazuhiko Nakamura; Norio Yasui-Furukori
Journal:  Neuropsychiatr Dis Treat       Date:  2014-08-22       Impact factor: 2.570

Review 3.  Using aripiprazole to reduce antipsychotic-induced hyperprolactinemia: meta-analysis of currently available randomized controlled trials.

Authors:  Meiling Meng; Wei Li; Shaowei Zhang; Hongyan Wang; Jianhua Sheng; Jijun Wang; Chunbo Li
Journal:  Shanghai Arch Psychiatry       Date:  2015-02-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.